Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Converting enzyme inhibition and heart failure.

B Magnani1

  • 1Institute of Cardiovascular Diseases, University of Bologna, Italy.

The American Journal of Medicine
|March 11, 1988
PubMed
Summary

Angiotensin converting enzyme inhibitors may benefit patients with mild to moderate heart failure. Early results suggest captopril use reduces diuretic needs and improves functional class compared to placebo.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frontiers of robotic endoscopic capsules: a review.

Journal of micro-bio robotics·2017
Same author

Severe postcardiac-transplant rejection associated with recurrence of giant cell myocarditis.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

[Respiratory function in tuberculous and post-tuberculous pulmonary fibrosis].

Rivista di patologia e clinica della tubercolosi·2014
Same author

An electromyographic study of the vastii muscles during open and closed kinetic chain submaximal isometric exercises.

International journal of sports physical therapy·2013
Same author

Pharmacological treatment of atrial fibrillation: a review on prevention of recurrences and control of ventricular response.

Archives of gerontology and geriatrics·2008
Same author

[Food intake and nutritional status in a group of healthy elderly residing in a nursing home].

Minerva gastroenterologica e dietologica·2006

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Angiotensin converting enzyme (ACE) inhibitors are established treatments for severe heart failure.
  • Their efficacy and safety in mild to moderate heart failure require further investigation.

Purpose of the Study:

  • To evaluate the effects of ACE inhibitors (captopril) versus placebo in patients with New York Heart Association functional class II and III heart failure.
  • To assess long-term outcomes and identify patient subgroups benefiting from ACE inhibition.

Main Methods:

  • A one-year, double-blind, placebo-controlled study involving 94 outpatients.
  • Patients received either captopril or placebo after initial stabilization with digoxin, with diuretic therapy withdrawn.
  • Assessments included symptom history, clinical examination, functional class, chest X-ray, ECG, Holter monitoring, echocardiography, and exercise testing.

Main Results:

  • Preliminary one-year data indicate a trend towards reduced diuretic requirements and improved New York Heart Association functional class in the captopril group compared to placebo.
  • No statistically significant differences were observed in noninvasive test results between groups.
  • Detailed analysis suggests potential advantages of ACE inhibitors for specific patient populations.

Conclusions:

  • ACE inhibitors like captopril may offer benefits in mild to moderate heart failure, particularly in managing symptoms and functional capacity.
  • Further research is ongoing to pinpoint which patient groups derive the most benefit from ACE inhibitor therapy.

Related Experiment Videos